Jeffrey Binder, chairman and chief executive officer of Cannabis Life Sciences (CLS), said in an interview last fall that his Colorado- and Nevada-based company is looking to expand—especially into states that have tight control over the number of marijuana dispensaries that are allowed to do business.
Massachusetts, with only 48 licensees, is such a state, Mr. Binder said during a September 2018 taped interview with Uptick News Wire.
“We intend to be one of the top players in the state of Massachusetts,” Mr. Binder said at the time.
Since then, CLS has entered into an agreement to acquire In Good Health, the Brockton-based company that has appeared before Sandwich selectmen in 2017, and again earlier this month, to ask for a letter of support to open a medical marijuana dispensary at 449 Route 130.
Last week the selectmen narrowly agreed to draft a so-called letter of non-opposition required by the state before a dispensary can open. Both selectmen who voted against providing the letter expressed doubts about who owns—or will own—In Good Health.
“I’m not questioning the legality or the use,” said selectman Shane T. Hoctor. “My concern is about the company and whether it is the right fit for us.”
Mr. Hoctor was referring to CLS, the company whose name was not revealed by In Good Health CEO David Noble when he appeared before the selectmen. Mr. Noble did say, under questioning by Mr. Hoctor, that In Good Health could ultimately be acquired by a Colorado-based company.